Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.61 USD | -2.99% | -2.92% | +15.57% |
07-02 | Concerns about particularly active hurricane season weigh on insurers | DP |
06-21 | Federal and state governments continue to wrestle over flood insurance | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.13 for the current year.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Reinsurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.57% | 66.71B | - | ||
+4.55% | 16.45B | B- | ||
+8.64% | 11.7B | C | ||
+5.26% | 2.07B | - | C+ | |
+6.29% | 1.81B | - | ||
+2.88% | 985M | - | ||
+47.31% | 658M | C+ | ||
-30.52% | 461M | C- | ||
+10.68% | 451M | - | C+ | |
+8.57% | 363M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MUV2 Stock
- MURGY Stock
- Ratings Munich Re